CORE EARNINGS PER SHARE: Core earnings per share are expected to rise to $2.07 from $1.45 the year prior, according to the same consensus. AstraZeneca's stock is up 7.9% since the start of 2024.

Equities research analysts at Cantor Fitzgerald lifted their FY2025 earnings per share (EPS) estimates for KLA in a note issued to investors on Friday, January 31st. Cantor Fitzgerald analyst C. Muse ...

Net Loss for the year ended December 31, 2024 was $88 million, compared to Net Income of $1.1 billion in the prior year.

Revenue1 increased 4% over prior year to $3.0 billion for the quarter and increased 5% to $9.9 billion for the yearOrganic Revenue growth of 5% for both the quarter and the yearDiluted Earnings per Sh ...

PepsiCo Inc. (NASDAQ:PEP) reported its fourth-quarter 2024 earnings with an earnings per share (EPS) of $1.96, slightly above ...

For the first quarter of fiscal 2025, net income attributable to Cabot Corporation was $93 million ($1.67 per diluted common ...

Meta Platforms has shown impressive growth, with strong quarterly and full-year financial results. See why I maintain a Hold ...

In its upcoming report, EnerSys (ENS) is predicted by Wall Street analysts to post quarterly earnings of $3.03 per share, reflecting an increase of 18.4% compared to the same period last year.

BASF's recent performance shows slight improvements, but the company still faces challenges. Check out why I think BASF stock ...

Pfizer reported robust fourth-quarter 2024 earnings, exceeding expectations in both revenue and adjusted earnings.

Reports Q4 revenue $27.78B, consensus $27.89B. “Our businesses remained resilient in 2024, despite subdued category performance trends in North ...

Reports Q1 revenue $750M vs. $634M last year. “Entering fiscal 2025, our teams have continued to execute well, driving an 18% increase in ...